게시물
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
102 좋아요5 싫어요10 리포스트1 댓글
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2mo
아직 댓글이 없습니다. 첫 댓글을 남겨보세요!
댓글
아직 댓글이 없습니다. 첫 댓글을 남겨보세요!